AI-Powered ASX Trading Signals

Real-time insights. Smarter decisions. Better trades.

🔍 Search Stocks 14 day Free Trial

EBR SYSTEMS INC (EBR)


AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for EBR during the last 90 days, indicating Moderate trading activity

Latest EBR Signals

13/05/2026SELL
30/03/2026SELL
29/03/2026SELL

EBR Share Price

Current Price$0.435
52 Week High$1.470
52 Week Low:$0.370
Trading at (% of 52 Week High) 29.59%


Volume 2969314
20 Day Avg 3380474
Relative Volume 87.8%


Business Overview

EBR Systems Inc (ASX: EBR) is a medical device company specializing in the development of innovative cardiac rhythm management technologies. The company focuses on creating leadless pacemaker systems designed to improve patient outcomes and simplify implantation procedures.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The SELL recommendation for EBR SYSTEMS INC is supported by bearish technical signals and weak recent performance, indicating a likely downward trend. However, moderate market volatility and sector-specific risks suggest some caution.

Latest  EBR SYSTEMS INC(EBR)   News

18 Mar 2026, 06:00 PM

Truffle Capital Unveils the First Edition of the Truffle MedTech 10

PARIS, March 18, 2026--(BUSINESS WIRE)--Truffle Capital, a leading European venture capital firm whose mission is to support the creation and growth of companies capable of becoming global leaders, unveils the Truffle MedTech 10 index. This is the first ranking of the top ten publicly traded compani

Unlock All ASX AI Signals

Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.

14 Day Free Trial • Cancel Anytime • Founders Price $15/month

Start My Free Trial